J Korean Ophthalmol Soc.
2005 Dec;46(12):1989-1994.
Photodynamic Therapy For Recurred Subfoveal Choroidal Neovascularization After Argon-Laser Photocoagulation
- Affiliations
-
- 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. hgonyu@snu.ac.kr
- 2Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.
Abstract
- PURPOSE
To evaluate the effects of photodynamic therapy for subfoveal recurrences of juxtafoveal or extrafoveal choroidal neovascularization (CNV), previously treated with argon-laser photocoagulation. METHODS: Seven eyes, previously treated with argon-laser photocoagulation for juxtafoveal or extrafoveal choroidal neovascularization, received photodynamic therapy for subfoveal recurrence. Changes in visual acuity and fluorescein angiographic findings were analyzed.
RESULTS
The average time of appearance of recurrent CNV after laser photocoagulation was 43.14+/-29.62 months (range, 2-77 months). After photodynamic therapy, fluorescein leakage and neovascular lesion size decreased in all patients on fluorescein angiography. Visual acuity was stabilized or improved in 5 of 7 eyes.
CONCLUSIONS
Photodynamic therapy was effective in patients with subfoveal recurrences of juxtafoveal or extrafoveal choroidal neovascularization previously treated with argon-laser photocoagulation.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Laser-Induced Choroidal Neovascularization in Central Serous Chorioretinopathy: 4 Cases
- The Clinical Manifestations and Treatments of Parafoveal Telangiectasis
- Two Cases of Choroidal Neovascularizatien After Photocoagulation
- Therapeutic Effect of Photodynamic Therapy with Indocyanine Green Dye in the Treatment of Choroidal Neovascularization
- Treatment of corneal neovascularization with argon laser
